Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital Evaluations and Technologies Enabling Clinical Translation for AD

NCT05385913 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT05385913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05385913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital Evaluations and Technologies Enabling Clinical Translation for AD
Lead sponsor
Oregon Health and Science University
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
September 30, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, early onset